Amgen on Tuesday reported fourth-quarter results that beat earnings expectations on a pro forma basis that excludes acquisition costs.

The Thousand Oaks drug maker reported net income of $1 billion ($1...

Join our Membership to get the full story.


Are you a current Member? Sign In